vs
MP Materials Corp.（MP）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
MP Materials Corp.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.5倍（$52.7M vs $35.5M），MP Materials Corp.净利率更高（17.9% vs -304.2%，领先322.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -13.6%），RECURSION PHARMACEUTICALS, INC.自由现金流更多（$-47.3M vs $-109.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 4.0%）
MP Materials Corp.是总部位于美国的稀土材料生产商，拥有并运营加利福尼亚州芒廷帕斯矿，这是西半球唯一在产的稀土开采及加工设施，所产核心材料可广泛应用于电动汽车、风力发电机、国防工业等多个关键领域。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
MP vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.7M | $35.5M |
| 净利润 | $9.4M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -7.0% | -304.8% |
| 净利率 | 17.9% | -304.2% |
| 营收同比 | -13.6% | 681.7% |
| 净利润同比 | 142.2% | 39.6% |
| 每股收益（稀释后） | $0.07 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $52.7M | $35.5M | ||
| Q3 25 | $53.6M | $5.2M | ||
| Q2 25 | $57.4M | $19.2M | ||
| Q1 25 | $60.8M | $14.7M | ||
| Q4 24 | $61.0M | $4.5M | ||
| Q3 24 | $62.9M | $26.1M | ||
| Q2 24 | $31.3M | $14.4M | ||
| Q1 24 | $48.7M | $13.8M |
| Q4 25 | $9.4M | $-108.1M | ||
| Q3 25 | $-41.8M | $-162.3M | ||
| Q2 25 | $-30.9M | $-171.9M | ||
| Q1 25 | $-22.6M | $-202.5M | ||
| Q4 24 | $-22.3M | $-178.9M | ||
| Q3 24 | $-25.5M | $-95.8M | ||
| Q2 24 | $-34.1M | $-97.5M | ||
| Q1 24 | $16.5M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -7.0% | -304.8% | ||
| Q3 25 | -125.2% | -3327.6% | ||
| Q2 25 | -76.5% | -916.8% | ||
| Q1 25 | -57.2% | -1297.9% | ||
| Q4 24 | -72.1% | -4042.4% | ||
| Q3 24 | -62.8% | -377.1% | ||
| Q2 24 | -171.1% | -697.4% | ||
| Q1 24 | -66.6% | -698.4% |
| Q4 25 | 17.9% | -304.2% | ||
| Q3 25 | -78.0% | -3135.3% | ||
| Q2 25 | -53.8% | -894.2% | ||
| Q1 25 | -37.2% | -1373.3% | ||
| Q4 24 | -36.6% | -3935.5% | ||
| Q3 24 | -40.5% | -367.5% | ||
| Q2 24 | -108.9% | -676.6% | ||
| Q1 24 | 33.9% | -662.4% |
| Q4 25 | $0.07 | $-0.17 | ||
| Q3 25 | $-0.24 | $-0.36 | ||
| Q2 25 | $-0.19 | $-0.41 | ||
| Q1 25 | $-0.14 | $-0.50 | ||
| Q4 24 | $-0.12 | $-0.56 | ||
| Q3 24 | $-0.16 | $-0.34 | ||
| Q2 24 | $-0.21 | $-0.40 | ||
| Q1 24 | $-0.08 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $743.3M |
| 总债务越低越好 | $998.7M | $9.6M |
| 股东权益账面价值 | $2.0B | $1.1B |
| 总资产 | $3.9B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.50× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $1.2B | $743.3M | ||
| Q3 25 | $1.1B | $659.8M | ||
| Q2 25 | $261.5M | $525.1M | ||
| Q1 25 | $198.3M | $500.5M | ||
| Q4 24 | $282.4M | $594.4M | ||
| Q3 24 | $284.4M | $427.6M | ||
| Q2 24 | $295.6M | $474.3M | ||
| Q1 24 | $296.5M | $296.3M |
| Q4 25 | $998.7M | $9.6M | ||
| Q3 25 | $997.3M | $11.9M | ||
| Q2 25 | $910.8M | $14.2M | ||
| Q1 25 | $909.8M | $16.4M | ||
| Q4 24 | $908.7M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $2.0B | $1.1B | ||
| Q3 25 | $2.0B | $1.0B | ||
| Q2 25 | $1.0B | $919.1M | ||
| Q1 25 | $1.0B | $933.9M | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $1.1B | $524.6M | ||
| Q2 24 | $1.1B | $584.4M | ||
| Q1 24 | $1.1B | $401.2M |
| Q4 25 | $3.9B | $1.5B | ||
| Q3 25 | $3.8B | $1.4B | ||
| Q2 25 | $2.3B | $1.3B | ||
| Q1 25 | $2.4B | $1.3B | ||
| Q4 24 | $2.3B | $1.4B | ||
| Q3 24 | $2.3B | $726.5M | ||
| Q2 24 | $2.4B | $775.9M | ||
| Q1 24 | $2.4B | $557.8M |
| Q4 25 | 0.50× | 0.01× | ||
| Q3 25 | 0.51× | 0.01× | ||
| Q2 25 | 0.90× | 0.02× | ||
| Q1 25 | 0.88× | 0.02× | ||
| Q4 24 | 0.86× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-46.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-109.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | -207.4% | -133.1% |
| 资本支出强度资本支出/营收 | 118.5% | 3.5% |
| 现金转化率经营现金流/净利润 | -4.97× | — |
| 过去12个月自由现金流最近4个季度 | $-328.1M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-46.9M | $-46.1M | ||
| Q3 25 | $-42.0M | $-117.4M | ||
| Q2 25 | $-3.7M | $-76.4M | ||
| Q1 25 | $-63.2M | $-132.0M | ||
| Q4 24 | $30.5M | $-115.4M | ||
| Q3 24 | $-6.8M | $-59.2M | ||
| Q2 24 | $30.8M | $-82.2M | ||
| Q1 24 | $-41.1M | $-102.3M |
| Q4 25 | $-109.3M | $-47.3M | ||
| Q3 25 | $-92.5M | $-117.6M | ||
| Q2 25 | $-32.7M | $-79.6M | ||
| Q1 25 | $-93.7M | $-133.8M | ||
| Q4 24 | $-11.2M | $-116.7M | ||
| Q3 24 | $-53.3M | $-63.8M | ||
| Q2 24 | $-15.6M | $-83.4M | ||
| Q1 24 | $-93.0M | $-109.0M |
| Q4 25 | -207.4% | -133.1% | ||
| Q3 25 | -172.8% | -2272.5% | ||
| Q2 25 | -56.9% | -413.9% | ||
| Q1 25 | -154.0% | -907.4% | ||
| Q4 24 | -18.3% | -2567.7% | ||
| Q3 24 | -84.7% | -244.6% | ||
| Q2 24 | -50.1% | -578.5% | ||
| Q1 24 | -191.0% | -789.9% |
| Q4 25 | 118.5% | 3.5% | ||
| Q3 25 | 94.3% | 4.7% | ||
| Q2 25 | 50.5% | 16.4% | ||
| Q1 25 | 50.1% | 12.4% | ||
| Q4 24 | 68.3% | 28.6% | ||
| Q3 24 | 73.8% | 17.5% | ||
| Q2 24 | 148.7% | 8.2% | ||
| Q1 24 | 106.5% | 48.2% |
| Q4 25 | -4.97× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MP
| Materials Segment | $35.6M | 68% |
| Other | $17.1M | 32% |
RXRX
暂无分部数据
